IDH1 and neoplasm: Glioblastoma diagnosis could be made using molecular criteria (TERTpromoter mutation,EGFRamplification, or gain of chromosome 7 with loss of chromosome10) regardless of histological features if the tumor is considered to be IDH-wildtype diffuse glioma.